Allos raises €4.2M Seed round
12 January 2026· Oxford, United Kingdom· health, pharmaceuticals, ai, biotech, b2b
To commercialize the industry's first "glass-box" Causal AI platform, accelerating the end-to-end reformulation of complex generic drugs.
Investors
LeadHabico Invest
Also participating
Oxford Science EnterprisesBerkeley SKYDECK
About Allos
Stage
Seed
Headquarters
Oxford, United Kingdom
Sectors
healthpharmaceuticalsaibiotechb2b